Announcements Trials
Browse Landscape

Phase

Phase 1 27Phase 2 3Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1

Status

Not yet recruiting 2Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 15Glioblastoma 14Neoplasms 12Melanoma 11Brain Neoplasms 11Head and Neck Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Lung Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Prostatic Neoplasms 8Glioma 8Ovarian Neoplasms 7Neoplasm Metastasis 7Lymphoma 6Colonic Neoplasms 6Multiple Myeloma 5Carcinoma, Hepatocellular 5Urinary Bladder Neoplasms 4Sarcoma 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Lymphoma, Large B-Cell, Diffuse 4Hodgkin Disease 4Stomach Neoplasms 3Recurrence 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Leukemia, Myeloid, Acute 3

Interventions

spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Terminated × Solid Tumors × Clear all
NCT04237649 2025-05-18

KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors

Novartis

Phase EARLY_PHASE1 Terminated
77 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡